MBK's 19-Day Pivot — From Blocked Makino Bid to Altemira Acquisition

[Makino (Makino Milling Machine Co., Ltd.)] Founded 1937, listed on the Tokyo Stock Exchange first section (code 6135). One of Japan's flagship machine-tool makers — world-class machining centers (MC), 5-axis precision machining, and electrical discharge machines (EDM). A common upstream supplier to automotive, aerospace, semiconductor equipment, medical device, and defense industries. Japan's government has long classified Makino's product family as [strategic-industry infrastructure]. Market cap ~¥200B as of April 2025.

[Nidec's hostile TOB.] On April 4, 2025, [Nidec — the world's largest precision motor maker, also listed on the TSE first section — launched a hostile tender offer for Makino] at ¥11,000 per share (+42% premium to prior close) for a total of ¥257B (~USD 1.78B). A listed-company hostile bid on another listed company is rare in Japan. Market note: the user's recollection that the hostile bidder was "another Japanese private equity fund" is incorrect per primary sources — the hostile bidder was Nidec, a listed motor conglomerate.

[Makino's defense — poison pill + court rejection of Nidec's injunction] On April 21, 2025, Makino's board resolved to adopt a [poison pill (free share-purchase rights)] and seek shareholder approval at the June annual general meeting. Nidec filed for an injunction at the Tokyo District Court, which was [rejected]. With the injunction path closed, [Nidec withdrew its TOB in May 2025] — barely a month after launch. The lesson for Makino's board: a poison pill stops one bidder but not the next. Mid-term [white-knight talks] began immediately.

[White-knight selection — Carlyle vs. MBK two-way race] Makino's board ran simultaneous talks with [Carlyle (US PE) and MBK Partners]. Both had strong Japan track records. In June 2025, [MBK secured preferred-bidder status]. Through a newly formed SPV [MM Holdings], MBK planned a full take-private tender at [¥11,751 per share (+6.8% above Nidec)] for a total of [~¥274.8B (~₩2T)]. U.S., Chinese, and European foreign-investment screenings all approved the transaction. Every approval step proceeded on schedule.

[April 22, 2026 — 18-year-first FEFTA cease recommendation.] One month before closing, on April 22, 2026, [Japan's Ministry of Finance and METI invoked Article 27, paragraph 5 of the FEFTA (Foreign Exchange and Foreign Trade Act) to issue a 'cease recommendation' (中止勧告) to MBK]. [The first such recommendation since the FEFTA amendment took effect in 2017, and the first cease recommendation of any kind since the 2008 TCI vs. J-Power dispute — 18 years.] The stated rationale: Makino's high-end machining centers are [dual-use technology] with implications for defense, aerospace, semiconductor, and medical device supply chains, and potential diversion to military applications. [Only Japan blocked the deal] — the U.S., China, and Europe had all already approved it.

[MBK's immediate withdrawal and 19-day pivot.] MBK accepted the recommendation within the 10-day window and withdrew the Makino TOB. Refusal would have escalated the action to a legally binding amendment / cease order and damaged MBK's long-term standing in the Japanese market. Then, [just 19 days after the withdrawal — on May 11, 2026 — MBK announced the acquisition of Altemira Holdings (Japan's #3 aluminum-can maker) from Apollo Global Management for ¥117.5B (¥130B including debt, ~₩1.1~1.2T)]. Despite Altemira's lithium-ion battery pouch production triggering [Core Industry] FEFTA pre-screening, the deal cleared in [approximately two months]. Same government, same PE firm — two opposite verdicts.

[MBK's firmwide AI — commonly known as Project Athena.] One reason cited in market discussion for the 19-day pivot is MBK's proprietary AI agent system. Chairman Michael ByungJu Kim has publicly stated, under the banner of ["Every business is an AI business,"] that MBK has built an AI decision-support system across sourcing, valuation, and portfolio management, with its agent system handling [more than 20,000 analytical and execution-support tasks per month]. Commonly referred to as [Project Athena] in market discussion, though the formal code name is not directly confirmed in primary sources. Where global mega-PE firms (Apollo, Blackstone, KKR) are moving toward [external AI licensing models], MBK is taking the [in-house AI operating model] path — a different track for automating decision-making at the GP level itself.